Sealed 1 v. Sealed 1

156 F. App'x 630
CourtCourt of Appeals for the Fifth Circuit
DecidedNovember 29, 2005
Docket04-41585
StatusUnpublished
Cited by10 cases

This text of 156 F. App'x 630 (Sealed 1 v. Sealed 1) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sealed 1 v. Sealed 1, 156 F. App'x 630 (5th Cir. 2005).

Opinion

CARL E. STEWART, Circuit Judge: *

This appeal arises from a qui tam action alleging violations of and retaliatory discharge under the False Claims Act, 31 U.S.C. § 3729. The principal issues on appeal are whether the relator satisfied the pleading requirements of Rule 9(b) of the Federal Rules of Civil Procedure and whether the relator stated a claim for retaliatory discharge. The district court dismissed the claims for failure to plead with particularity pursuant to Rule 9(b) and failure to state a claim pursuant to Rule *632 12(b)(6). For the following reasons, we affirm.

I. FACTUAL AND PROCEDURAL BACKGROUND

Sealed Appellee I (“Appellee”) is an ambulance service company. Sealed Appellant I (“Appellant”) was originally hired by Appellee’s parent company as Compliance Manager to oversee regulatory compliance in the eastern United States. Federal regulations require that an ambulance company obtain the patient’s signature before the company can bill the government for its services. In his capacity as Compliance Manager, Appellant became aware of complaints about the lack of patient signatures from one of Appellee’s billing supervisors and several billing clerks. In response, Appellant wrote a compliance intake form to his supervisor informing him of the billing clerks’ complaints. He was later promoted to Director of Compliance for Appellee. In that capacity, Appellant conducted a company wide audit to evaluate the extent of the patient signature problem. This audit revealed that in several regions in the United States, a number of offices were noncompliant. Specifically, the audit revealed that in Kennesaw, Georgia, the best regional billing office, noncompliance in the patient signature area was thirty-four percent while the worst regional billing office, Portland, Oregon, was ninety-four percent noncompliant. After the auditor removed those files that had a “lifetime signature” from the noncompliant category, the noncompliance rate improved to between thirty-five and forty percent company wide. Appellant then used the data from the audit to extrapolate how much Appellee had billed the government and concluded that Appellee had falsely billed the government approximately $200 million annually.

In July 2001, Appellant reported the results of the audit in a memorandum addressed to Appellee’s Chief Compliance Officer and distributed it to several of Appellee’s executive officers. Appellant also gave a presentation about the problem at a compliance retreat in August 2001. On or about August 31, 2001, Appellee’s supervisor called Appellant away from his office in Aurora, Colorado, to a staff meeting in Arlington, Texas, but fired Appellant before the meeting began. Appellant was unable to retrieve from his office his personal effects or documentation that supported his allegations. Appellant contends that this was done to bar his access to the documents necessary to be more specific in his allegations.

Appellant subsequently filed a qui tarn suit alleging violations of the FCA and retaliatory discharge. The government declined to intervene. Appellee filed a motion to dismiss for failure to state a claim. The district court granted Appellee’s motion to dismiss as to Appellant’s claims of violation of the FCA as well as his claim of retaliatory discharge. Appellant timely filed notice of appeal. 1

II. DISCUSSION

A. Violation of the FCA

Claims brought under the FCA must be pleaded with particularity pursuant to Federal Rule of Civil Procedure 9(b). United States ex rel. Doe v. Dow Chemical Co., 343 F.3d 325, 328 (5th Cir. 2003). A dismissal for failure to meet the requirements of Rule 9(b) is a dismissal *633 for failure to state a claim, thus review is de novo. Id. We also review a dismissal for failure to state a claim under Rule 12(b)(6) de novo. Id.

To satisfy Rule 9(b) the complaint must allege the “who, what, when, where, and how of the alleged fraud.” United States ex rel. Thompson v. Columbia/HCA Healthcare Corp., 125 F.3d 899, 903 (5th Cir.1997) (internal quotations omitted) (quoting Williams v. WMX Tech., Inc., 112 F.3d 175, 179 (5th Cir.1997)). Appellant alleged that Appellee violated the FCA by sending bills for ambulance runs representing that the patients’ signatures were on file, when Appellee knew that the signatures were not on file. He further alleged that these violations occurred nationwide and cost the government approximately $200 million annually spanning a period of five years, “[fjrom 1999 to the present.”

Appellant has failed to plead any particular facts showing that Appellee was aware of the actions of its employees and intentionally filed false claims with the government. The complaint alleges that when Appellant conducted training sessions with the billing clerks, they complained that they were required to check the box indicating the patient’s signature was on file when they knew there was no signature on file. Appellant asserts that he did not name the individual billing clerks because he contends that seventy-five individual corporations perpetrated the fraud. The complaint alleges that Appellant told his supervisor about the billing clerks’ complaints and that Appellee’s vice president criticized Appellant for instructing the clerks not to bill without a signature. Thereafter, Appellant was promoted to Director of Compliance and, in that capacity, he conducted an audit and submitted the results in a memo to, inter alia, Appellee’s corporate officers. These are the only allegations that Appellee was aware of the actions of its employees. The complaint includes no more than the conclusory assertions of Appellee’s knowledge and intent to file fraudulent claims. Cf. United States ex rel. Williams v. Bell Helicopter Textron, Inc., 417 F.3d 450, 454 (5th Cir.2005) (“Williams’ complaint fails to plead any particular facts showing that Bell Helicopter was aware of the actions of its employees, [and] that it had intentionally filed these false claims with the government. ...”). Further, the complaint alleges that on or about August 31, 2001, Appellant was fired, but does not allege how Appellant knows that Appellee submitted false billing statements after that time. The audit only spanned one year, thus the allegations of fraud outside of that time frame are based on Appellant’s extrapolations and good faith belief; this is simply not sufficient under Rule 9(b). See Columbia/HCA Healthcare,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Key Energy Services, Inc. Securities Litigation
166 F. Supp. 3d 822 (S.D. Texas, 2016)
Newby v. Enron Corp.
540 F. Supp. 2d 759 (S.D. Texas, 2007)
Northwest Bypass Group v. U.S. Army Corps of Engineers
488 F. Supp. 2d 22 (D. New Hampshire, 2007)
In Re Enron Corporation Securities, Derivative
540 F. Supp. 2d 759 (S.D. Texas, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
156 F. App'x 630, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sealed-1-v-sealed-1-ca5-2005.